Fexinidazole
Fexinidazole
Fexinidazole (pronounced: feks-in-id-a-zole) is an antiprotozoal medication used for the treatment of African trypanosomiasis, also known as sleeping sickness. It is the first all-oral treatment approved for both stages of sleeping sickness.
Etymology
The term "Fexinidazole" is derived from the chemical structure of the drug, which is a 2-substituted 5-nitroimidazole.
Usage
Fexinidazole is used for the treatment of human African trypanosomiasis caused by Trypanosoma brucei gambiense. It is effective in both the first (hemolymphatic) and second (meningoencephalitic) stages of the disease. The drug is administered orally, which makes it a more convenient option than the previously used treatments that required parenteral administration.
Mechanism of Action
Fexinidazole works by inhibiting the DNA synthesis of the Trypanosoma brucei parasite, thereby killing it. The drug is a prodrug, which means it is metabolized in the body to its active form.
Side Effects
Common side effects of Fexinidazole include nausea, vomiting, decreased appetite, headache, dizziness, and rash. Severe side effects may include QT prolongation, a type of heart rhythm disorder.
Related Terms
External links
- Medical encyclopedia article on Fexinidazole
- Wikipedia's article - Fexinidazole
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski